Robert Ouvrier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert Ouvrier has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Monique M. Ryan
Department of Neurology, The Royal Children’s Hospital, Melbourne, Vic, Australia
2 shared publications Angelika F. Hahn
Department of Clinical Neurological Sciences, London Health Sciences Center, University Campus, London, Ontario, Canada
1 shared publicationAnn Bye
Department of Neurology, Sydney Children's Hospital, Randwick, Australia
1 shared publicationChris Rittey
1 shared publicationColeen Adams
1 shared publicationDavid Ramsay
1 shared publication
Latest Publications
- 17 February 2011
- Published by Springer Nature in Journal of Neurology
- Vol. 258 (8) , 1571-1572
Henri Parinaud (1844–1905)
- 17 February 2011
- Published by Springer Nature in Journal of Neurology
- Vol. 258 (8) , 1571-1572
Henri Parinaud (1844–1905)
- 4 March 2010
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 52 (4) , 328-330
Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults
Mitofusin 2, a large transmembrane GTPase located in the outer mitochondrial membrane, promotes membrane fusion and is involved in the maintenance of the morphology of axonal mitochondria. Mutations of the gene encoding mitofusin 2 (MFN2) have recently been identified as the cause of approximately one‐third of dominantly inherited cases of the axonal degenerative forms of Charcot–Marie–Tooth disease (CMT type 2A) and of rarer variants. The latter include a severe, early‐onset axonal neuropathy, which may occur in autosomal dominant or recessive forms, as well as some instances associated with pyramidal tract involvement (CMT type 5), with optic atrophy (CMT type 6), and, occasionally, with alterations of cerebral white matter. All individuals with a dominantly or recessively inherited or otherwise unexplained, chronic progressive axonal degenerative polyneuropathy should be tested for mutations of MFN2.
- 4 March 2010
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 52 (4) , 328-330
Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults
Mitofusin 2, a large transmembrane GTPase located in the outer mitochondrial membrane, promotes membrane fusion and is involved in the maintenance of the morphology of axonal mitochondria. Mutations of the gene encoding mitofusin 2 (MFN2) have recently been identified as the cause of approximately one‐third of dominantly inherited cases of the axonal degenerative forms of Charcot–Marie–Tooth disease (CMT type 2A) and of rarer variants. The latter include a severe, early‐onset axonal neuropathy, which may occur in autosomal dominant or recessive forms, as well as some instances associated with pyramidal tract involvement (CMT type 5), with optic atrophy (CMT type 6), and, occasionally, with alterations of cerebral white matter. All individuals with a dominantly or recessively inherited or otherwise unexplained, chronic progressive axonal degenerative polyneuropathy should be tested for mutations of MFN2.
- 1 October 2007
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 14 (10) , 1009
306: A prospective study of critical illness polyneuropathy in childhood
- 1 October 2007
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 14 (10) , 1009
306: A prospective study of critical illness polyneuropathy in childhood
- 4 April 2007
- Published by Wiley in Muscle & Nerve
- Vol. 36 (2) , 131-143
Autosomal‐recessive and X‐linked forms of hereditary motor and sensory neuropathy in childhood
The hereditary motor and sensory neuropathies (HMSNs, Charcot–Marie–Tooth neuropathies) are the most common degenerative disorders of the peripheral nervous system. In recent years a dramatic expansion has occurred in our understanding of the molecular basis and cell biology of the recessively inherited demyelinating and axonal neuropathies, with delineation of a number of new neuropathies. Mutations in some genes cause a wide variety of clinical, neurophysiologic, and pathologic phenotypes, rendering diagnosis difficult. The X‐linked forms of HMSN represent at least 10%–15% of all HMSNs and have an expanded disease spectrum including demyelinating, intermediate, and axonal neuropathies, transient central nervous system (CNS) dysfunction, mental retardation, and hearing loss. This review presents an overview of the recessive and X‐linked forms of HMSN observed in childhood, with particular reference to disease phenotype and neurophysiologic and pathologic abnormalities suggestive of specific diagnoses. These findings can be used by the clinician to formulate a differential diagnosis and guide targeted genetic testing. Muscle Nerve, 2007
- 4 April 2007
- Published by Wiley in Muscle & Nerve
- Vol. 36 (2) , 131-143
Autosomal‐recessive and X‐linked forms of hereditary motor and sensory neuropathy in childhood
The hereditary motor and sensory neuropathies (HMSNs, Charcot–Marie–Tooth neuropathies) are the most common degenerative disorders of the peripheral nervous system. In recent years a dramatic expansion has occurred in our understanding of the molecular basis and cell biology of the recessively inherited demyelinating and axonal neuropathies, with delineation of a number of new neuropathies. Mutations in some genes cause a wide variety of clinical, neurophysiologic, and pathologic phenotypes, rendering diagnosis difficult. The X‐linked forms of HMSN represent at least 10%–15% of all HMSNs and have an expanded disease spectrum including demyelinating, intermediate, and axonal neuropathies, transient central nervous system (CNS) dysfunction, mental retardation, and hearing loss. This review presents an overview of the recessive and X‐linked forms of HMSN observed in childhood, with particular reference to disease phenotype and neurophysiologic and pathologic abnormalities suggestive of specific diagnoses. These findings can be used by the clinician to formulate a differential diagnosis and guide targeted genetic testing. Muscle Nerve, 2007
- 1 April 2005
- Published by Elsevier in Brain and Development
- Vol. 27 (3) , 185-188
Paroxysmal tonic upgaze of childhood—a review
- 1 April 2005
- Published by Elsevier in Brain and Development
- Vol. 27 (3) , 185-188
Paroxysmal tonic upgaze of childhood—a review
- 15 May 2001
- Published by Wiley in Muscle & Nerve
- Vol. 24 (6) , 760-768
Severe infantile axonal neuropathy with respiratory failure
We describe 5 infants (4 male, 1 female) with a severe intractable form of motor‐sensory axonal neuropathy. All became ventilator‐dependent, 4 have since died and 1 remains static. Diaphragmatic paralysis was an early feature with generalized neuropathy evolving rapidly. Nerve conduction studies and biopsies were consistent with axonal disease. This disorder could be a new condition or part of the spectrum of inherited neuropathies of the axonal degenerative type. It may be that there is a “switching‐off” in the infant's Schwann cell–axonal interactions in utero or in the early postnatal period, resulting in severe progressive deterioration and then a static period without recovery. © 2001 John Wiley & Sons, Inc. Muscle Nerve 24: 760–768, 2001
- 15 May 2001
- Published by Wiley in Muscle & Nerve
- Vol. 24 (6) , 760-768
Severe infantile axonal neuropathy with respiratory failure
We describe 5 infants (4 male, 1 female) with a severe intractable form of motor‐sensory axonal neuropathy. All became ventilator‐dependent, 4 have since died and 1 remains static. Diaphragmatic paralysis was an early feature with generalized neuropathy evolving rapidly. Nerve conduction studies and biopsies were consistent with axonal disease. This disorder could be a new condition or part of the spectrum of inherited neuropathies of the axonal degenerative type. It may be that there is a “switching‐off” in the infant's Schwann cell–axonal interactions in utero or in the early postnatal period, resulting in severe progressive deterioration and then a static period without recovery. © 2001 John Wiley & Sons, Inc. Muscle Nerve 24: 760–768, 2001